Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1786 1
1795 1
1797 1
1799 1
1814 1
1816 1
1818 1
1819 1
1822 2
1824 1
1828 3
1829 1
1830 2
1831 2
1832 2
1833 2
1834 1
1835 1
1837 1
1840 3
1841 7
1842 4
1843 3
1844 4
1845 5
1846 9
1847 5
1848 2
1849 2
1850 4
1851 3
1852 6
1853 4
1854 1
1855 2
1856 4
1857 2
1858 1
1859 1
1860 3
1861 2
1862 1
1864 2
1866 4
1867 8
1868 4
1869 3
1870 3
1871 2
1872 11
1873 5
1874 12
1875 7
1876 5
1877 7
1878 14
1879 2
1880 5
1881 11
1882 8
1883 11
1884 10
1885 7
1886 4
1887 10
1888 9
1889 7
1890 9
1891 3
1892 10
1893 7
1894 18
1895 12
1896 12
1897 20
1898 24
1899 23
1900 9
1901 28
1902 18
1903 10
1904 26
1905 32
1906 15
1907 21
1908 24
1909 31
1910 16
1911 34
1912 23
1913 26
1914 24
1915 17
1916 25
1917 30
1918 25
1919 14
1920 13
1921 27
1922 24
1923 32
1924 28
1925 40
1926 31
1927 34
1928 33
1929 36
1930 45
1931 43
1932 36
1933 42
1934 33
1935 43
1936 32
1937 39
1938 37
1939 25
1940 38
1941 30
1942 21
1943 19
1944 16
1945 213
1946 647
1947 790
1948 891
1949 841
1950 1302
1951 1510
1952 1541
1953 1668
1954 1784
1955 1901
1956 1964
1957 2156
1958 1994
1959 2077
1960 2137
1961 2451
1962 2682
1963 3975
1964 5600
1965 4753
1966 4993
1967 5942
1968 7272
1969 8047
1970 8191
1971 8922
1972 9486
1973 9473
1974 10123
1975 9940
1976 9377
1977 9343
1978 9507
1979 10072
1980 10277
1981 10450
1982 10808
1983 11306
1984 12006
1985 12395
1986 12354
1987 12896
1988 13268
1989 14515
1990 14321
1991 14430
1992 14525
1993 14579
1994 14922
1995 14963
1996 15645
1997 15449
1998 15643
1999 15369
2000 15638
2001 16174
2002 16970
2003 18106
2004 19107
2005 20432
2006 21456
2007 22100
2008 24023
2009 24846
2010 26001
2011 28103
2012 31149
2013 31752
2014 33100
2015 34106
2016 34723
2017 35481
2018 36569
2019 38375
2020 44452
2021 48280
2022 46253
2023 44133
2024 16391

Text availability

Article attribute

Article type

Publication date

Search Results

1,079,166 results

Results by year

Filters applied: . Clear all
Page 1
Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC. Li SC. Pediatr Clin North Am. 2018 Aug;65(4):757-781. doi: 10.1016/j.pcl.2018.04.002. Pediatr Clin North Am. 2018. PMID: 30031497 Review.
Scleroderma is a rare disease that has two main forms: localized scleroderma (LS) and systemic sclerosis (SSc). ...Mortality is extremely rare in juvenile LS, but morbidity is common, with patients at risk for severe disfigurement and functional impair …
Scleroderma is a rare disease that has two main forms: localized scleroderma (LS) and systemic sclerosis (SSc). …
Localized scleroderma: clinical spectrum and therapeutic update.
Careta MF, Romiti R. Careta MF, et al. An Bras Dermatol. 2015 Jan-Feb;90(1):62-73. doi: 10.1590/abd1806-4841.20152890. An Bras Dermatol. 2015. PMID: 25672301 Free PMC article. Review.
Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin an …
Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, an …
Scleroderma with an update about clinico-pathological correlation.
Rongioletti F, Ferreli C, Atzori L, Bottoni U, Soda G. Rongioletti F, et al. G Ital Dermatol Venereol. 2018 Apr;153(2):208-215. doi: 10.23736/S0392-0488.18.05922-9. Epub 2018 Jan 24. G Ital Dermatol Venereol. 2018. PMID: 29368844 Free article. Review.
Scleroderma is divided into a systemic form called systemic sclerosis and a localized form also called morphea. ...Localized scleroderma (LS) or morphea includes a number of subtypes which are classified more according to their clinical p …
Scleroderma is divided into a systemic form called systemic sclerosis and a localized form also called morphea. …
Gastrointestinal involvement in systemic sclerosis: An updated review.
Nassar M, Ghernautan V, Nso N, Nyabera A, Castillo FC, Tu W, Medina L, Ciobanu C, Alfishawy M, Rizzo V, Eskaros S, Mahdi M, Khalifa M, El-Kassas M. Nassar M, et al. Medicine (Baltimore). 2022 Nov 11;101(45):e31780. doi: 10.1097/MD.0000000000031780. Medicine (Baltimore). 2022. PMID: 36397401 Free PMC article. Review.
The gastrointestinal tract (GI) is the second most affected organ system in individuals suffering from systemic/localized scleroderma (SSc) or localized scleroderma. SSc can affect any part of the GI, between the oral cavity and anorectum. ...Es …
The gastrointestinal tract (GI) is the second most affected organ system in individuals suffering from systemic/localized s …
Localized and systemic scleroderma.
Hawk A, English JC 3rd. Hawk A, et al. Semin Cutan Med Surg. 2001 Mar;20(1):27-37. doi: 10.1053/sder.2001.23093. Semin Cutan Med Surg. 2001. PMID: 11308134 Review.
Scleroderma is a broad term encompassing both localized and systemic sclerosis. ...Systemic scleroderma (sclerosis) can manifest as either limited or diffuse disease. ...
Scleroderma is a broad term encompassing both localized and systemic sclerosis. ...Systemic scleroderma ( …
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T. Knobler R, et al. J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1401-1424. doi: 10.1111/jdv.14458. Epub 2017 Aug 9. J Eur Acad Dermatol Venereol. 2017. PMID: 28792092
Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum....
Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea …
Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
Distler O, Cozzio A. Distler O, et al. Semin Immunopathol. 2016 Jan;38(1):87-95. doi: 10.1007/s00281-015-0551-z. Epub 2015 Nov 17. Semin Immunopathol. 2016. PMID: 26577237 Review.
Systemic sclerosis (SSc) is a chronic autoimmune disease with a high morbidity and mortality. ...Herein, we also give a state of the art overview of the current classification, clinical presentation, diagnostic approach, and treatment options of localized sclerod …
Systemic sclerosis (SSc) is a chronic autoimmune disease with a high morbidity and mortality. ...Herein, we also give a state of the …
Systemic and localized scleroderma.
Chung L, Lin J, Furst DE, Fiorentino D. Chung L, et al. Clin Dermatol. 2006 Sep-Oct;24(5):374-92. doi: 10.1016/j.clindermatol.2006.07.004. Clin Dermatol. 2006. PMID: 16966019 Review.
We now have some moderately effective therapies for vascular aspects of systemic sclerosis (eg, bosentan for pulmonary arterial hypertension, calcium-channel blockers for Raynaud's, or angiotensin-converting enzyme inhibitors for renal crisis). We also are beginning to fin …
We now have some moderately effective therapies for vascular aspects of systemic sclerosis (eg, bosentan for pulmonary arterial hyper …
Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review.
McGaugh S, Kallis P, De Benedetto A, Thomas RM. McGaugh S, et al. Dermatol Ther. 2022 Jun;35(6):e15437. doi: 10.1111/dth.15437. Epub 2022 Mar 22. Dermatol Ther. 2022. PMID: 35278019 Review.
Morphea and systemic sclerosis (SSc) are rare disorders of connective tissue characterized by increased skin thickness and fibrosis, with current treatment options having variable efficacies, many with limited therapeutic benefit. Janus kinase (JAK) inhibitors have been sh …
Morphea and systemic sclerosis (SSc) are rare disorders of connective tissue characterized by increased skin thickness and fibrosis, …
Pediatric scleroderma: systemic or localized forms.
Torok KS. Torok KS. Pediatr Clin North Am. 2012 Apr;59(2):381-405. doi: 10.1016/j.pcl.2012.03.011. Epub 2012 Apr 6. Pediatr Clin North Am. 2012. PMID: 22560576 Free PMC article. Review.
Pediatric scleroderma includes 2 major groups of clinical entities, systemic sclerosis (SSc) and localized scleroderma (LS). ...
Pediatric scleroderma includes 2 major groups of clinical entities, systemic sclerosis (SSc) and localized scleroder …
1,079,166 results
You have reached the last available page of results. Please see the User Guide for more information.